A Medical Device Daily

Micell Technologies (Raleigh, North Carolina) reported that it has engaged Foster-Miller (Boston) for further development work and automation of its manufacturing process for creating drug-eluting coatings for medical devices.

Under the agreement, the project will include phased development of systems and manufacturing engineering related to Micell's cardiovascular drug-eluting stent (DES) coating process, providing Micell with a manufacturing system to realize benefits in process efficiency and performance.

Arthur Benvenuto, CEO and chairman of Micell, said, “In addition to their broad experience in developing automated manufacturing systems for the biomedical industry, Foster-Miller has a demonstrated ability to engineer breakthrough concepts that target major markets.”

Micell is a private early-stage biomedical company developing combination product therapies in the cardiovascular, orthopedic and drug-delivery sectors, using supercritical fluids for improving current polymer based drug-eluting technologies.

Foster-Miller, a technology development firm, is certified to Aerospace Quality Management Standard AS9100 and has SW-CMM Level 3 software certification from the Software Engineering Institute at Carnegie Mellon University. It is an independent, wholly owned subsidiary of QinetiQ North America.

VivoMetrics Government Services (Ventura, California) reported that theLifeShirt ambulatory physiologic monitoring system is now offered on the Federal Supply Services Contract, which includes GSA and VA schedules, to all federal U.S. Government organizations.

The LifeShirt is a machine-washable garment with embedded sensors that measure respiration, ECG, body position and activity and correlates these objective measures with subjective patient input.

The GSA/VA Schedules help federal agencies serve the public by negotiating on behalf of all federal government to provide best value for acquisition services and process management. By adding the LifeShirt to the GSA/VA Schedule, U.S. government agencies can now purchase the product with a simple purchase order.

VivoMetrics describes itself as “the world leader in ambulatory physiologic monitoring devices for first responders, pharmaceutical clinical trials and academic research.”